Baloxavir is an antiviral active pharmaceutical ingredient used in the manufacturing of medications for influenza A and B. It is the parent compound of baloxavir marboxil, which is administered orally and can reduce flu symptom duration by about 1–2 days.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing or supplying this compound?
List your inventory or post a purchase request
CAS 1985605-59-1
1H-[1,4]Oxazino[3,4-c]pyrido[2,1-f][1,2,4]triazine-6,8-dione, 12-[(11S)-7,8-difluoro-6,11-dihydrodibenzo[b,e]thiepin-11-yl]-3,4,12,12a-tetrahydro-7-(phenylmethoxy)-, (12aR)-
pharmaceutical intermediate
Favipiravir
pharmaceutical raw material
Ensitrelvir fumarate
pharmaceutical raw material
2-amino-1,9-dihydro-9-((1S,3R,4S)-4-(benzyloxy)-3-(benzyloxymethyl)-2-methylene cyclopentyl)-6H-purine-6-one
pharmaceutical raw material
Cidofovir dihydrate
pharmaceutical raw material
Baloxavir marboxil
pharmaceutical raw material
(1R,2S)-tranylcypromine hydrochloride
pharmaceutical raw material
Lisuride maleate
pharmaceutical raw material
(3R)-2-[(11S)-7,8-difluoro-6,11-dihydrobenzo[c][1]benzothiepin-11-yl]-11-hydroxy-5-oxa-1,2,8-triazatricyclo[8.4.0.03,8]tetradeca-10,13-diene-9,12-dione
FIDLLEYNNRGVFR-CTNGQTDRSA-N
C1COC[C@@H]2N1C(=O)C3=C(C(=O)C=CN3N2[C@H]4C5=C(CSC6=CC=CC=C46)C(=C(C=C5)F)F)O